We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
OMCL vs. VEEV: Which Stock Should Value Investors Buy Now?
Read MoreHide Full Article
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL - Free Report) and Veeva Systems (VEEV - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.
Currently, Omnicell has a Zacks Rank of #1 (Strong Buy), while Veeva Systems has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that OMCL has an improving earnings outlook. But this is just one factor that value investors are interested in.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
OMCL currently has a forward P/E ratio of 16.49, while VEEV has a forward P/E of 33.69. We also note that OMCL has a PEG ratio of 0.67. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. VEEV currently has a PEG ratio of 0.96.
Another notable valuation metric for OMCL is its P/B ratio of 1.36. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, VEEV has a P/B of 6.77.
Based on these metrics and many more, OMCL holds a Value grade of B, while VEEV has a Value grade of D.
OMCL sticks out from VEEV in both our Zacks Rank and Style Scores models, so value investors will likely feel that OMCL is the better option right now.
View the Zacks #1 Rank List
Image: Bigstock
OMCL vs. VEEV: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL - Free Report) and Veeva Systems (VEEV - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.
Currently, Omnicell has a Zacks Rank of #1 (Strong Buy), while Veeva Systems has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that OMCL has an improving earnings outlook. But this is just one factor that value investors are interested in.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
OMCL currently has a forward P/E ratio of 16.49, while VEEV has a forward P/E of 33.69. We also note that OMCL has a PEG ratio of 0.67. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. VEEV currently has a PEG ratio of 0.96.
Another notable valuation metric for OMCL is its P/B ratio of 1.36. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, VEEV has a P/B of 6.77.
Based on these metrics and many more, OMCL holds a Value grade of B, while VEEV has a Value grade of D.
OMCL sticks out from VEEV in both our Zacks Rank and Style Scores models, so value investors will likely feel that OMCL is the better option right now.